MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
CAS No. : 19237-84-4
MCE 国际站:Prazosin hydrochloride
产品活性:Prazosin hydrochloride 是一种耐受良好、具有 CNS 活性的 α1-肾上腺素能受体(α1-adrenergic receptor) 拮抗剂。 可用于研究高血压和酒精使用障碍。 Prazosin hydrochloride 有效抑制去甲肾上腺素 (NE) 刺激的 45Ca 流出,IC50 为 0.15 nM。Prazosin hydrochloride 抑制有机阳离子转运蛋白 OCT-1 和 OCT-3,IC50 分别为 1.8 和 13 μM 。
研究领域:GPCR/G Protein | Neuronal Signaling | Autophagy
作用靶点:Adrenergic Receptor | Autophagy
In Vitro: Prazosin (0, 2.5, 5, 7.5, 10, 15, 20, 30, 40 and 50 μM) effectively inhibits the proliferation of U251 and U87 cells.
?Prazosin inhibits the migration and invasion of U251 and U87 cells.
?Prazosin treatment decreases the protein expression of components of the PI3K/AKT/mTOR signaling pathway. Prazosin (13.16 and 11.57 μM for U251 and U87 cells, 48 hours) decreases the expression levels of P70 and cyclin D1, which are downstream target genes of the PI3K/AKT/mTOR signaling pathway.
In Vivo: Peripheral administration of Prazosin (0, 0.5, 1.0, 1.5 or 2.0 mg/kg; i.p.) can suppress not only central α1-adrenergic-mediated hyperexcitability but also stress-induced anxiety.
相关产品:Drug Repurposing Compound Library Plus | FDA-Approved Drug Library Plus | FDA-Approved Drug Library Mini | Bioactive Compound Library Plus | GPCR/G Protein Compound Library | Neuronal Signaling Compound Library | FDA-Approved Drug Library | Anti-Cancer Compound Library | Autophagy Compound Library | Drug Repurposing Compound Library | Anti-Cardiovascular Disease Compound Library | Endocrinology Compound Library | Anti-COVID-19 Compound Library | NMPA-Approved Drug Library | Orally Active Compound Library | Neurotransmitter Receptor Compound Library | FDA Approved & Pharmacopeial Drug Library | Anti-Alzheimer's Disease Compound Library | Drug-Induced Liver Injury (DILI) Compound Library | Neurodegenerative Disease-related Compound Library | Antidepressant Compound Library | FDA-Approved Anticancer Drug Library | Human Metabolite Library | Coagulation and Anti-coagulation Compound Library | Heterocyclic Compound Library | Off-patent Drug Library | Antihypertensive Compound Library | Membrane Protein-targeted Compound Library | Membrane Receptor-targeted Compound Library | Perphenazine-d8 dihydrochloride | Desglymidodrine | PF-610355 | Adrenaline sulfate | Nadolol | ARC 239 | Todralazine | Amibegron hydrochloride | N-5984 | Zotepine | Paliperidone-d4 | Yohimbine | Clenproperol-d7 | (R)-(+)-Atenolol | Salbutamol | Formoterol fumarate | Metoprolol-d6 tartrate | Moprolol | Clonidine-d4 hydrochloride | Pindolol-d7 | Clorprenaline | Nifenalol hydrochloride | Trifluoperazine dihydrochloride | Bromchlorbuterol hydrochloride | Paliperidone | Navafenterol | Droxidopa-13C2,15N hydrochloride | Ecopipam | Alfuzosin-d3
热门产品线:重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物 | 寡核苷酸 | 抗体 | 点击化学
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides | Antibodies | Click Chemistry
品牌介绍:
• MCE (MedChemExpress) 拥有200 多种全球独家化合物库,我们致力于为全球科研客户提供前沿最全的高品质小分子活性化合物;
• 50,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领;
• 产品种类涵盖各种重组蛋白,多肽,常用试剂盒 ,更有 PROTAC、ADC 等特色产品,广泛应用于新药研发、生命科学等科研项目;
• 提供虚拟筛选,离子通道筛选,代谢组学分析检测分析,药物筛选等专业技术服务;
• 设有专业的实验中心和严格的质控、验证体系;
• 提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告,确保产品的高纯度、高品质;
• 产品的生物活性多经各国客户实验验证;
• Nature, Cell, Science 等多种顶级期刊及制药专利收录了MCE客户的科研成果;
• 专业团队跟踪最新的制药及生命科学研究进展,为您提供全球最新的活性化合物;
• 与世界各大制药公司及知名科研机构建立了长期的合作。